The FAMHP is addressing the concerns of healthcare professionals. To cope with the difficulties in supplying medicinal products, FAMHP experts are in constant contact with hospital pharmacies and are working tirelessly to find solutions. There is currently no shortage of medicinal products preventing the treatment of COVID-19 patients in Belgium.
Coronavirus: the FAMHP continues to supply essential medicinal products for intensive care and provides hospitals with daily updates
Following the recommendations of the Belgian National Security Council regarding the coronavirus epidemic, the FAMHP encourages employees to work more from home. Therefore, we ask all our partners to submit their files to us electronically as much as possible.
Following the coronavirus epidemic (COVID-19), experts at FAMHP are actively monitoring the potential impact on the availability of medication and medical devices in Belgium. The FAMHP is also supporting the European Medicines Agency (EMA) in developing COVID-19 vaccines.